Thyroid ultrasound surveillance had low clinical utility among pediatric patients with DTC who exhibited excellent initial treatment response.

PYX-201 has gained FDA fast track designation in recurrent or metastatic head and neck squamous cell carcinoma.

Treatment of thyroid nodules and differentiated thyroid cancer can generally be safely postponed until after delivery. As diagnosing thyroid diseases during pregnancy may be difficult, adequate ...

Welcome to the Veracyte fourth quarter and full year 2024 financial results webcast. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...

AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the ...

Q4 2024 Earnings Call Transcript February 24, 2025 Veracyte, Inc. beats earnings expectations. Reported EPS is $0.36, ...

A new groundbreaking study revealed that recombinant human thyrotropin (SNA001) is as efficient as thyroid hormone withdrawal ...

AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, announced today two poster presentations ...

The leading Advanced Merkel Cell Carcinoma Companies such as Xencor, Inc., Incyte Corporation, Millennium Pharmaceuticals, ...

Exposure to high-normal, compared with low-normal, TSH levels was not associated with an elevated risk for differentiated thyroid cancer recurrence after thyroidectomy. Exposure to high-normal ...

Some of its key products include CABOMETYX, a drug for advanced renal cell carcinoma (RCC); and COMETRIQ capsules to treat ...

Growth and Innovation: Proceeds from the transaction are expected to further fuel Aspire's strategic growth plan to accelerate the development of its differentiated pipeline ... post-surgery, cancer ...